Jul 30
|
Immutep Quarterly Activities Report Q4 FY25
|
Jul 29
|
3 ASX Penny Stocks With Market Caps Under A$400M To Watch
|
Jul 29
|
Immutep to Present Pivotal TACTI-004 Trial in Progress Poster at the 2025 World Conference on Lung Cancer
|
Jul 28
|
Immutep Announces Abstracts Accepted for Presentation at the European Society for Medical Oncology Congress 2025
|
Jul 24
|
High Growth Tech Stocks To Watch In Australia July 2025
|
Jul 22
|
High Growth Tech Stocks in Australia for July 2025
|
Jul 21
|
Exploring Three High Growth Tech Stocks in Australia
|
Jul 20
|
High Growth Tech Stocks in Australia Featuring Life360 and Two Others
|
Jul 2
|
Exploring Three High Growth Tech Stocks In Australia
|
Jun 29
|
Immutep (IMMP) Announces Positive Initial Efficacy Data and Continued Favourable Safety Data
|
May 5
|
Immutep’s Efti in Combination with KEYTRUDA® (pembrolizumab) Drives Strong Overall Survival in Head and Neck Cancer with CPS <1
|
Mar 10
|
Immutep Limited (IMMP): Among the Best Australian Stocks to Buy According to Billionaires
|
Feb 11
|
Is Immutep Limited (IMMP) the Best Long Term ASX Stock to Buy Now?
|
Jan 31
|
Immutep Quarterly Activities Report Q2 FY25
|
Jan 31
|
Is Immutep Limited (IMMP) One of the Best ASX Stocks to Buy According to Hedge Funds?
|
Jan 27
|
Why Immutep (IMMP) Is Among the Best Australian Stocks to Buy Now?
|